Abstract: 5-Alkyl-6-(substituted benzyl)-2-thiouracils 3a,c were reacted with (2-chloroethyl) diethylamine hydrochloride to afford the corresponding 2-(2-diethylamino)ethylthiopyrimidin-4(3H)-ones 4a,b. Reaction of 3a-c with N-(2-chloroethyl)pyrrolidine hydrochloride and/or N-(2-chloroethyl) 3a, 3b, 4a, 5a, 5b, 6d, 6f, 7b and 7d, whereas compounds 4b, 5b, 5c, 6a, 6b and 6f exhibited the best antifungal activity.
Introduction
In chemotherapy pyrimidines are considered as privileged structures with a large spectrum of biological activities. They are known very widely in Nature since they are components of RNA and DNA. The chemotherapeutic efficacy of pyrimidines may be due to their ability to inhibit vital enzymes responsible for nucleic acid biosynthesis such as reverse transcriptase, dihydrofolate reductase, uridine and thymidine phosphorylase, as well as thymidylate synthetase. Several pyrimidine derivatives exhibit diverse pharmacological activities as antiviral [1] [2] [3] [4] [5] [6] [7] [8] [9] , anti-inflammatory [10] [11] [12] , and antimalarial agents [13] [14] [15] . Many pyrimidines have been demonstrated to possess anticancer [16] [17] [18] [19] [20] [21] , antituberculosis [22] and anti-allergic [23] activities. Moreover, several pyrimidine derivatives have been reported as antithyroid [24] and antimicrobial agents [25] [26] [27] [28] [29] [30] , as well as human thymidine and uridine phosphorylase inhibitors [31] [32] [33] .
In a previous study [34] , we synthesized a series of 2-(substituted amino)ethylthiopyrimidines analogues of S-DABOs to be screened as reverse transcriptase inhibitors against human immunodeficiency virus (HIV-1). We found it of interest to evaluate the antimicrobial activity for such pyrimidine derivatives. In the present work, and as a part of our continuing interest in the chemistry of pyrimidines [30, [34] [35] [36] [37] [38] [39] [40] [41] [42] , the synthesis and antimicrobial evaluation of some novel 2-(substituted amino)alkylthiopyrimidin-4(3H)-one derivatives have been investigated.
Results and Discussion

Chemistry
5-Alkyl-6-(substituted benzyl)-2-thiouracils 3a-d were prepared, as described in our previous work [34, 42] , by reaction of (substituted phenyl)acetonitrile 1 with the appropriate ethyl 2-bromoesters 2 in anhydrous THF in the presence of zinc dust, followed by treatment of the β-ketoesters thus formed with thiourea in the presence of sodium ethoxide. Compounds 3a and 3c were reacted with (2-chloroethyl) diethylamine hydrochloride in DMF in the presence of anhydrous potassium carbonate to afford 6-(4-chlorobenzyl)-2-(2-diethylamino)ethylthio-5-methylpyrimidin-4(3H)-one (4a) [34] and 6-(3,4-dimethoxybenzyl)-2-(2-diethylamino)ethylthio-5-ethylpyrimidin-4(3H)-one (4b) in good yields (Scheme 1).
[34] and 6-(3,4-dimethoxybenzyl)-5-ethyl-2-[2-(pyrrolidin-1-yl)ethyl]thiopyrimidin-4(3H)-one (5c) were obtained, respectively, in good yields, on reaction of compounds 3a, 3b and/or 3c with N-(2-chloroethyl)pyrrolidine hydrochloride in the presence of anhydrous potassium carbonate in DMF (Scheme 2). Alkylation of 3b and/or 3c with N-(2-chloroethyl)piperidine hydrochloride in DMF containing potassium carbonate gave 6-(4-chlorobenzyl)-5-ethyl-2-[2-(piperidin-1-yl)ethyl]thiopyrimidin-4(3H)-one (6a) [34] On the other hand, compounds 3a and 3b were treated with N-(2-bromoethyl)phthalimide and/or N- (3-bromopropyl) phthalimide in the presence of potassium carbonate in DMF to furnish the corresponding 2-[2-(N-phthalimido)ethyl]pyrimidines 7a,b and 2-[3-(N-phthalimido)propyl]-pyrimidines 7c,d in 69%, 71% and 62%, 64% yields, respectively (Scheme 2).
Antimicrobial Testing
The antimicrobial activities of the synthesized compounds, 3a-d, 4a,b, 5a-c, 6a-f and 7a-d (200 µg/10 mm disc) as well as the reference drugs, ampicillin and clotrimazole, were screened against yeast-like pathogenic fungus (Candida albicans ATCC 10231), fungus (Aspergillus niger NRRL 599) and Gram-positive bacteria (Staphylococcus aureus ATCC 29213, Bacillus subtilis NRRL 4219 and Bacillus cereus) which are important human pathogenic microorganisms. A Diameter of Inhibition Zone (DIZ) assay [43] was performed to evaluate the preliminary antimicrobial potential of the test compounds against the test organisms and the results are given in Table 1 . The synthesized compounds showed varying degrees of inhibition zones against the tested microorganisms. The antibacterial results revealed that compounds 3a, 3b, 4a, 5a, 5b, 6a-d, 6f, 7a, 7b and 7d showed strong activity (growth inhibition zones > 18 mm against one or more of the tested microorganisms), compound 6e exhibited weak activity (growth inhibition zone 10-13 mm), while compounds 3c, 3d, 4b, 5c and 7c showed no antibacterial activity (growth inhibition zones < 10 mm). Concerning the antifungal results, compounds 3b, 4b, 5b, 5c, 6a, 6b, 6f and 7a exhibited strong activity, compounds 3a, 6d and 7c showed moderate activity (growth inhibition zones 14-18 mm), compounds 4a, 5a, 7b and 7d showed weak activity, whereas no antifungal activity was noticed for compounds 3c, 3d, 6c and 6e. In general, the best antibacterial activity was displayed by compounds 3a, 3b, 4a, 5a, 5b, 6d, 6f, 7b and 7d. Compounds 4b, 5b, 5c, 6a, 6b and 6f exhibited the best antifungal activity, whereas compounds 3c and 3d showed no activity against the test organisms. Gram-positive bacteria, Staphylococcus aureus, and the yeast-like, Candida albicans, are considered the most sensitive among the tested microorganisms. The synthesized test compounds showed no activity against Gram negative pathogens, Escherichia coli and Pseudomonas aeruginosa. Although several compounds showed strong antibacterial and antifungal activities, none of them were found to be superior to the reference drugs. Compounds 3a, 3b, 4a, 5a, 5b, 6b, 6d, 6f, 7b and 7d displayed a relatively broad spectrum activity, accordingly, their MIC values were determined. The MIC values for compounds 3a, 3b, 4a, 5a, 5b, 6b, 6d, 6f, 7b and 7d against the most sensitive tested microorganisms, Staphylococcus aureus and Candida albicans are represented in Table 2 . According to the above results, the antimicrobial activity seemed to be dependent on the nature of substituents. Compounds containing a 4-chlorobenzyl substituent at C-6 of the pyrimidine ring showed the best antibacterial activity, whereas, the best antifungal results were given by compounds containing 2-(pyrrolidin-1-yl)ethylthio and 2-(piperidin-1-yl)ethylthio substituents at C-2 of the pyrimidine ring. Concerning compounds 7a-d, the ethyl group at C-5 of the ring was found to improve the antimicrobial activity.
Experimental
General
Melting points (°C) were measured in open glass capillaries using a Branstead 9100 Electrothermal melting point apparatus and are uncorrected. NMR spectra were obtained on a Bruker AC 500 Ultra Shield NMR spectrometer (Fällanden, Switzerland) operating at 500. 13 3a-d, 4a, 5a ,b and 6a were reported in our previous studies [34, 42] .
General Procedure for Preparation of 2-(Substituted amino)ethylthiopyrimidines 4b, 5c and 6b-f
To a solution of the appropriate compound 3a-d (1 mmol) in anhydrous DMF (5 mL), was added anhydrous potassium carbonate (0.304 g, 2.2 mmol) followed by the appropriate 2-chloroethyl substituted amine hydrochloride (1.1 mmol). The mixture was stirred at room temperature for 24 h, then was diluted with H 2 O (100 mL) and extracted with diethyl ether (3 × 50 mL). The combined organic extract was washed with H 2 O (3 × 50 mL), dried (MgSO 4 ) and evaporated under reduced pressure. The residue was chromatographed on silica gel column with CHCl 3 to afford the target compounds. 
6-(3,4-Dimethoxybenzyl)-2-[2-(diethylamino)ethy]lthio-5-ethylpyrimidin-4(3H)-one
6-(3,4-Dimethoxybenzyl)-5-ethyl-2-[2-(pyrrolidin-1-yl)ethyl]thiopyrimidin-4(3H)-one
6-(4-Chlorobenzyl)-5-methyl-2-[2-(morpholin-4-yl)ethyl]thiopyrimidin-4(3H)-one
6-(4-Chlorobenzyl)-5-ethyl-2-[2-(morpholin-4-yl)ethyl]thiopyrimidin-4(3H)-one
5-Ethyl-6-(4-methylbenzyl)-2-[2-(morpholin-4-yl)ethyl]thiopyrimidin-4(3H)-one
6-(3,4-Dimethoxybenzyl)-5-ethyl-2-[2-(morpholin-4-yl)ethyl]thiopyrimidin-4(3H)-one
General Procedure for Preparation of 2-[2-(N-Phthalimido)ethyl]thiopyrimidin-4(3H)-ones 7a,b and 2-[3-(N-Phthalimido)propyl]thiopyrimidin-4(3H)-ones 7c,d
Anhydrous potassium carbonate (0.152 g, 1.1 mmol) was added to a solution of the appropriate compound 3a,b (1 mmol) in DMF (5 mL), followed by addition of N-(2-bromoethyl)phthalimide and/ or N-(3-bromopropyl)phthalimide (1.1 mmol) . The reaction mixture was stirred at room temperature for 24 h and worked up as described above for the preparation of compounds 4-6. [43] Sterile nutrient, Czapek's dox and malt extract agar media were inoculated, separately, with 100 µL cell suspension of the chosen microorganism, bacteria, fungi and yeast-like fungi, respectively, and poured into Petri-dishes (20 cm diameter). The test compounds (200 µg/10 mm diameter disc) were placed onto the surface of the agar Petri-dishes. The antimicrobial activities were expressed as the diameter of the growth inhibition zone in mm. [44] The minimal inhibitory concentrations (MICs) of the test compounds were determined using serial dilutions technique. Different concentrations ranging 50.0-200.0 µg/mL for each compound in dimethyl sulphoxide (DMSO) were placed on filter paper disc (1 cm diameter). The discs were deposited on the surface of inoculated agar plates and kept at low temperature before incubation which favours diffusion over microbial growth to detect the inhibition zone clearly. The plates were incubated at 30 °C for 24 h for bacteria and yeast and for 48 h for fungi.
6-(4-Chlorobenzyl)-5-methyl-2-[2-(N-phthalimido)ethyl]thiopyrimidin-4(3H)-one
6-(4-Chlorobenzyl)-5-ethyl-2-[2-(N-phthalimido)ethyl]thiopyrimidin-4(3H)-one
6-(4-Chlorobenzyl)-5-methyl-2-[3-(N-phthalimido)propyl]thiopyrimidin-4(3H)-one
6-(4-Chlorobenzyl)-5-ethyl-2-[3-(N-phthalimido)propyl]thiopyrimidin-4(3H)-one
Determination of the Antimicrobial Activity by the Agar Disc-Diffusion Method
Determination of Minimal Inhibitory Concentration (MIC)
Conclusions
In the present study, several 2-(substituted amino)alkylthiopyrimidin-4(3H)-ones were synthesized and screened against Gram-positive bacteria (Staphylococcus aureus ATCC 29213, Bacillus subtilis NRRL 4219 and Bacillus cereus), yeast-like pathogenic fungus (Candida albicans ATCC 10231) and fungus (Aspergillus niger NRRL 599) which are important human pathogenic microorganisms. Most of the test compounds showed good antimicrobial activities.
